Correlation Between Broadcom and Telo Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Broadcom and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Broadcom and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Broadcom and Telo Genomics Corp, you can compare the effects of market volatilities on Broadcom and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Broadcom with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Broadcom and Telo Genomics.

Diversification Opportunities for Broadcom and Telo Genomics

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Broadcom and Telo is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Broadcom and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Broadcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Broadcom are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Broadcom i.e., Broadcom and Telo Genomics go up and down completely randomly.

Pair Corralation between Broadcom and Telo Genomics

Assuming the 90 days trading horizon Broadcom is expected to generate 0.43 times more return on investment than Telo Genomics. However, Broadcom is 2.31 times less risky than Telo Genomics. It trades about 0.09 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about 0.0 per unit of risk. If you would invest  2,023  in Broadcom on August 30, 2024 and sell it today you would earn a total of  1,795  from holding Broadcom or generate 88.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy60.93%
ValuesDaily Returns

Broadcom  vs.  Telo Genomics Corp

 Performance 
       Timeline  
Broadcom 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Broadcom has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Broadcom is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Telo Genomics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Telo Genomics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Broadcom and Telo Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Broadcom and Telo Genomics

The main advantage of trading using opposite Broadcom and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Broadcom position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.
The idea behind Broadcom and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope